Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ever Fortune.AI Co., Ltd. (6841:TWSE), powered by AI.
Ever Fortune.AI Co., Ltd. is currently trading at $60.60. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ever Fortune.AI Co., Ltd. on Alpha Lenz.
View Ever Fortune.AI Co., Ltd.'s valuation metrics on Alpha Lenz.
“Ever Fortune.AI Co., Ltd.'s ROE is 4.7%. Explore profitability and growth together.”
Ask for details →Ever Fortune.AI Co., Ltd. is a technology company specializing in artificial intelligence solutions for the healthcare sector. With a focus on medical big data and cloud-based biomedical platforms, the company leverages advanced AI technologies to assist in diagnostics and disease prediction. Key products include systems for radiographic bone age interpretation, height prediction, ultrasound-based tumor classification, liver cancer metastasis risk management, liver fibrosis evaluation, and cardiac arrhythmia detection—all designed to enable more efficient and precise medical analysis and decision-making. These tools integrate genetic, physiological, and imaging data to create comprehensive AI prediction models widely used by hospitals and medical professionals. Ever Fortune.AI Co., Ltd. plays a significant role in driving the transformation of healthcare delivery by providing customized AI technology solutions that enhance clinical workflows and patient outcomes. As part of its ongoing growth strategy, the company is also involved in joint ventures to develop generative AI healthcare robots, reflecting its commitment to addressing the global shortage of healthcare professionals and advancing automation in medicine.
“Ever Fortune.AI Co., Ltd.'s ROE is 4.7%. Explore profitability and growth together.”
Ask for details →Ever Fortune.AI Co., Ltd. (ticker: 6841) is a company listed on TWSE in the Healthcare sector (Health Information Services). It has approximately 74 employees.
The current price is 60.6 with a P/E ratio of -x and P/B of -x.
ROE is 4.70% and operating margin is 10.18%. Annual revenue is $379M.